In Vivo Bioavailability-Bioequivalence Studies – Clinical
Similar Posts
Lupin Limited Unit 2 – 7/17/2025
Lupin Limited Unit 2 – 7/17/2025. Country: India. Record Type: 483Spring & Mulberry Issues Voluntary Recall of Mint Leaf Date Sweetened Chocolate Bar Due to Possible Salmonella Contamination
Raleigh, North Carolina (January 12, 2026) — Spring & Mulberry is voluntarily recalling lot #025255 of its Mint Leaf Date Sweetened Chocolate Bar (2.1 oz) due to possible contamination with Salmonella.Columbia Cosmetics Manufacturing Inc. – 710885 – 09/11/2025
CGMP/Finished Pharmaceuticals/AdulteratedPediatric Exclusivity Granted
Approved active drugs with sponsors to which FDA has granted exclusivity for pediatric studies under Section 505A of the Federal Food, Drug, and Cosmetic Act (FD&C Act)Continuous Glucose Monitoring Software Correction: Dexcom Issues Correction for Dexcom G6 and G6 Pro Software
A defect was discovered in the Dexcom G6 and G6 Pro Android US CGM App version 1.15.0 that may cause the app to shut down unexpectedly.FDA approves belantamab mafodotin-blmf for relapsed or refractory multiple myeloma
On October 23, 2025, the Food and Drug Administration approved belantamab mafodotin-blmf (Blenrep, GlaxoSmithKline), a B-cell maturation antigen (BCMA)-directed antibody and microtubule inhibitor conjugate, with bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma who